...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Re: from IR "Hepalink does not own Zenith shares."

actually i believe Kbc corrected me on this a while back.

Thats good , no hearing how a chinese company could or would effect a sale as some have mentioned in regards to rvx.

Share
New Message
Please login to post a reply